PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS

抗肿瘤/HIV药物的药理学研究

• 批准号: 3610248
• 负责人: JOHN MCCORMACK
• 金额: $ 10.53万
• 依托单位: UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
• 依托单位国家: 美国
• 财政年份: 1991
• 资助国家: 美国
• 起止时间: 1991-11-15 至 1994-11-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3610248
• 关键词: antiAIDS agent; antineoplastics; antiviral agents; clearance rate; dogs; drug administration rate /duration; drug administration routes; drug metabolism; drug screening /evaluation; laboratory mouse; laboratory rat; method development; pharmacokinetics

The Contractor shall furnish services, qualified personnel, material, equipment and facilities, not otherwise provided by the Government to perform assignments for Preclinical Pharmacology studies of Antitumor and Anti-HIV agents in body fluids and/or tissues of animals at know effective antitumor or antiviral concentrations. Task assignments will be issued under this Cost Reimbursement/Level of Effort contract which allows the Government to exercise control in scheduling and directing the studies.

承包商应提供服务、合格人员、材料， 设备和设施，而不是由政府提供， 执行抗肿瘤的临床前药理学研究任务， 已知有效的动物体液和/或组织中的抗HIV药物 抗肿瘤或抗病毒浓度。 将发布任务分配 根据本成本补偿/工作量水平合同， 政府在安排和指导研究方面行使控制权。